Anzeige
Mehr »
Sonntag, 19.10.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CGS | ISIN: US4618741098 | Ticker-Symbol:
NASDAQ
13.10.25 | 21:55
12,990 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXOZYMES INC Chart 1 Jahr
5-Tage-Chart
EXOZYMES INC 5-Tage-Chart

Aktuelle News zur EXOZYMES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.10.EXOZYMES INC. - 8-K, Current Report2
30.09.Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees230LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals...
► Artikel lesen
12.08.eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today324Management to host earnings call at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered...
► Artikel lesen
12.08.EXOZYMES INC. - 10-Q, Quarterly Report4
08.08.eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST309LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals...
► Artikel lesen
EXOZYMES Aktie jetzt für 0€ handeln
29.07.eXoZymes achieves 99% purity in lab-scale NCT production1
29.07.eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity414Using eXoZymes' AI-driven exozymes platform, NCTx has demonstrated lab scale validation with 4 grams of NCT produced at a 96% yield and with a purity higher than 99%.NCT project went from concept to...
► Artikel lesen
22.07.eXoZymes meldet Durchbruch bei Bioproduktion von NCT3
22.07.eXoZymes achieves breakthrough in NCT biomanufacturing process2
22.07.eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months451N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial...
► Artikel lesen
07.07.Hedge Fund and Insider Trading News: Bill Ackman, Michael Platt, Scott Bessent, Point72 Asset Management, Berkshire Hathaway, Lakehouse Capital, Exozymes Inc (EXOZ), and More38
26.06.eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing370MONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines...
► Artikel lesen
20.06.EXOZYMES INC. - 8-K, Current Report1
16.05.eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast462MONROVIA, CALIFORNIA / ACCESS Newswire / May 16, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals...
► Artikel lesen
13.05.eXoZymes reports Q1 results2
12.05.eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today312Management to host earnings call at 5:00PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that...
► Artikel lesen
12.05.EXOZYMES INC. - 10-Q, Quarterly Report3
07.05.eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST409MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines,...
► Artikel lesen
06.05.eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health309N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier...
► Artikel lesen
25.04.EXOZYMES INC. - S-8, Securities to be offered to employees in employee benefit plans2
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1